Therapeutic effects of 1,25-dihydroxyvitamin D3 on diabetes-induced liver complications in a rat model

Experimental and Therapeutic Medicine

Volumn 11, Issue 6, 2016, Pages 2284-2292

  Liu, Lina ^a   Lv, Guodong ^a   Ning, Conghua ^a   Yang, Ye ^a   Zhu, Jun ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Insulin resistance; Liver; Type 2 diabetes mellitus; Vitamin D

Indexed keywords

BETA ACTIN; CALCITRIOL; CYTOKINE; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LIVER DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

EID: 84964068094     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.3242     Document Type: Article

References (40)

1. Guadarrama-López AL, Valdés-Ramos R and Martínez-Carrillo BE: Type 2 diabetes, PUFAs, and vitamin D: Their relation to inflammation. J Immunol Res 2014: 860-703, 2014.
2. Flores M: A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus? Nutr Res Rev 18: 175-182, 2005.
3. Chiu KC, Chu A, Go VL and Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79: 820-825, 2004.
4. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE and Hu FB: Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29: 650-656, 2006.
5. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
6. Gregor MF and Hotamisligil GS: Inflammatory mechanisms in obesity. Ann Rev Immunol 29: 415-445, 2011.
7. Sattar N, McCarey DW, Capell H and McInnes IB: Explaining how 'high-gradeʼ systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108: 2957-2963, 2003.
8. Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y and Schattner A: Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol 98: 2751-2756, 2003.
9. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R and Mathieu C: Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77: 47-57, 2007.
10. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G and Arcaro G: Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17: 517-524, 2007.
11. Laskin DL, Weinberger B and Laskin JD: Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 70: 163-170, 2001.
12. Korf H, Wenes M, Stijlemans B, Takiishi T, Robert S, Miani M, Eizirik DL, Gysemans C and Mathieu C: 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology 217: 1292-1300, 2012.
13. Alroy I, Towers TL and Freedman LP: Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15: 5789-5799, 1995.
14. Ip YT and Davis RJ: Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10: 205-219, 1998.
15. Karin M and Gallagher E: From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57: 283-295, 2005.
16. Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y, Matsuhisa M, Yamasaki Y and Hori M: Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem 279: 45803-45809, 2004.
17. Yang R and Trevillyan JM: c-Jun N-terminal kinase pathways in diabetes. Int J Biochem Cell Biol 40: 2702-2706, 2008.
18. Sharfi H and Eldar-Finkelman H: Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling. Am J Physiol Endocrinol Metab 294: E307-E315, 2008.
19. Kaneto H: The JNK pathway as a therapeutic target for diabetes. Expert Opin Ther Targets 9: 581-592, 2005.
20. Tarantino G and Caputi A: JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J Gastroenterol 17: 3785-3794, 2011.
21. Chagas CE, Borges MC, Martini LA and Rogero MM: Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4: 52-67, 2012.
22. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M and Hotamisligil GS: Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci USA 103: 10741-10746, 2006.
23. Micheau O and Tschopp J: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190, 2003.
24. Seki E, Brenner DA and Karin M: A liver full of JNK: Signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143: 307-320, 2012.
25. Schwabe RF, Uchinami H, Qian T, Bennett BL, Lemasters JJ and Brenner DA: Differential requirement for c-Jun NH2-terminal kinase in TNF alpha-and Fas-mediated apoptosis in hepatocytes. FASEB J 18: 720-722, 2004.
26. Li H, Xie H, Fu M, Li W, Guo B, Ding Y and Wang Q: 25-hydroxyvitamin D3 ameliorates periodontitis by modulating the expression of inflammation-associated factors in diabetic mice. Steroids 78: 115-120, 2013.
27. Hotamisligil GS, Shargill NS and Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
28. Bieghs V and Trautwein C: The innate immune response during liver inflammation and metabolic disease. Trends Immunol 34: 446-452, 2013.
29. Negrin KA, Roth Flach RJ, DiStefano MT, Matevossian A, Friedline RH, Jung D, Kim JK and Czech MP: IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis. PloS One 9: e107265, 2014.
30. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T and Donath MY: Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356: 1517-1526, 2007.
31. Moore M, Piazza A, Nolan Y and Lynch MA: Treatment with dexamethasone and vitamin D3 attenuates neuroinflammatory age-related changes in rat hippocampus. Synapse 61: 851-861, 2007.
32. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Görgün C, Glimcher LH and Hotamisligil GS: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461, 2004.
33. Nguyen MT, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, Zalevsky J, Dahiyat BI, Chi NW and Olefsky JM: JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 280: 35361-35371, 2005.
34. Meeker S, Seamons A, Paik J, Treuting PM, Brabb T, Grady WM and Maggio-Price L: Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res 74: 4398-4408, 2014.
35. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB and Zhang X: 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev 24: 459-464, 2008.
36. Scragg R, Sowers M and Bell C; Third National Health and Nutrition Examination Survey: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care 27: 2813-2818, 2004.
37. von Hurst PR, Stonehouse W and Coad J: Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br J Nutr 103: 549-555, 2010.
38. Hotamisligil GS: Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
39. Nugent DA, Smith DM and Jones HB: A review of islet of Langerhans degeneration in rodent models of type 2 diabetes. Toxicol Pathol 36: 529-551, 2008.
40. 3 on glucose homeostasis and DNA damage in type 2 diabetic mice. J Diabetes Complications 26: 363-368, 2012.